MPM
BIO icon

Meritage Portfolio Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Meritage Portfolio Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-29,397
Closed -$22.2M – 338
2021
Q4 		$22.2M Sell
29,397
-412
-1% -$308K 1.26% 16
2021
Q3 		$22.2M Buy
29,809
+34
+0.1% +$25.5K 1.33% 13
2021
Q2 		$19.2M Sell
29,775
-311
-1% -$189K 1.16% 17
2021
Q1 		$17.2M Sell
30,086
-1,231
-4% -$729K 1.15% 19
2020
Q4 		$18.3M Buy
31,317
+133
+0.4% +$75.7K 1.34% 16
2020
Q3 		$16.1M Sell
31,184
-104
-0.3% -$52.7K 1.44% 15
2020
Q2 		$14.1M Buy
31,288
+1,204
+4% +$531K 1.36% 19
2020
Q1 		$10.5M Buy
+30,084
New +$11.1M 1.43% 17

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return